DATI EPIDEMIOLOGICI: Global, regional and national burden of skin and subcutaneous diseases: a systematic analysis of the Global Burden of Disease Study 2021

Skin and subcutaneous diseases represent a significant global health challenge, affecting millions of people worldwide. The Global Burden of Disease Study 2021 provides comprehensive data on the prevalence, incidence, and impact of these conditions across different regions and countries. This presentation examines the key findings, highlighting disparities in disease burden and the need for targeted interventions to improve skin health outcomes globally.

Overview of Skin Diseases

• Skin diseases encompass a wide range of conditions, including dermatitis, psoriasis, and skin cancers
• These conditions vary in severity, from mild irritations to life-threatening complications
• The burden of skin diseases is often underestimated due to underreporting and lack of awareness
• Skin diseases can significantly impact quality of life, mental health, and economic productivity

Global Burden of Skin Diseases

• Dermatitis and eczema are among the most common skin conditions globally
• Skin cancers, including melanoma, contribute to substantial morbidity and mortality
• Infectious skin diseases, such as leprosy and scabies, remain prevalent in low-resource settings
• The economic cost of skin diseases includes direct healthcare expenses and indirect costs from lost productivity

Regional Disparities in Skin Disease Burden

• High-income countries report higher rates of skin cancers due to lifestyle factors and UV exposure
• Low- and middle-income countries face a higher burden of infectious and neglected tropical skin diseases
• Access to dermatological care varies significantly, with rural and underserved populations often lacking resources
• Climate and environmental factors influence the prevalence of certain skin conditions in different regions

Key Findings from the Global Burden of Disease Study 2021

• The study reveals a growing burden of skin diseases, particularly in aging populations
• Psoriasis and atopic dermatitis show increasing prevalence, driven by genetic and environmental factors
• Skin diseases disproportionately affect vulnerable populations, including children and the elderly
• The study underscores the need for improved surveillance, prevention, and treatment strategies

Conclusion

The Global Burden of Disease Study 2021 provides critical insights into the prevalence and impact of skin and subcutaneous diseases worldwide. The findings highlight the need for targeted public health interventions, improved access to care, and increased awareness to address the growing burden of these conditions. By leveraging these data, policymakers and healthcare providers can develop more effective strategies to reduce the global impact of skin diseases and improve patient outcomes.